Glukóza Viaflo Baxter

Glukóza Viaflo Baxter is an intravenous glucose solution containing the active ingredient glucose. It is supplied in a sterile liquid form for infusion. The product is manufactured for the EU market and is used as a source of carbohydrate energy in clinical settings. It provides a readily available source of glucose for patients requiring intravenous nutrition or fluid replacement and may be administered under medical supervision.

Glukóza Viaflo Baxter is commonly employed in hospital environments for several therapeutic purposes related to carbohydrate provision and fluid management.

- To supplement caloric intake in patients unable to eat or drink orally. - To correct or prevent hypoglycemia during surgery, critical illness, or fasting. - To serve as a carrier for intravenous medications that require a glucose‑containing diluent. - To maintain plasma osmolarity and support fluid balance in perioperative or trauma care.

Intravenous glucose solutions can produce a range of reactions, most of which are mild and transient, while rare serious events may occur.

Common: - Mild hyperglycemia or transient rise in blood glucose levels. - Local irritation or redness at the infusion site. - Nausea or mild abdominal discomfort. - Fluid overload when large volumes are infused rapidly.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reaction such as rash, itching, or anaphylaxis. - Electrolyte imbalance, particularly low potassium, with rapid glucose shifts.

Healthcare professionals should observe several precautions when using Glukóza Viaflo Baxter to ensure patient safety.

- Verify patient’s blood glucose level before and during infusion. - Adjust infusion rate in patients with renal or cardiac insufficiency. - Avoid use in individuals with known hypersensitivity to glucose solutions. - Monitor electrolytes, especially potassium, during prolonged administration. - Use aseptic technique to prevent contamination of the intravenous line. - Consider reduced concentrations for neonates or pediatric patients. - Document infusion details in the patient’s medical record.

Glucose infusions can interact with other medications or clinical conditions; awareness of these interactions helps guide safe administration.

Avoid: - Avoid concurrent administration of high‑dose insulin without close glucose monitoring. - Avoid mixing with medications that are unstable in a carbohydrate solution (e.g., certain antibiotics).

Use with caution: - Use with caution when patients are receiving diuretics, as fluid shifts may affect electrolyte balance. - Use with caution in patients on beta‑blockers, which can mask signs of hypoglycemia. - Use with caution alongside corticosteroids, which may increase blood glucose levels.